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Abstract 
Rats with myocardial infarction provide a clinically relevant model for hemodynamic and survival studies. Moreover, behavioral 
changes in this model, i.e. increased anxiety and reduced interest in environment and social interactions, mimic aspects of the reduced 
quality of life of patients. In the present study, we investigated whether pharmacological treatment that is known to improve 
hemodynamics and prognosis could also affect the behavioral changes associated with quality of life. Rats with 3-week-old infarcts were 
treated with intermittent dobutamine (1 mg/kg i.p., twice daily) or captopril (2 g/l in drinking water). After 2 weeks of treatment, when 
from previous studies hemodynamics are expected to be restored, behavioral tests were performed. In the free exploration test, which 
primarily evaluates exploratory behavior, dobutamine normalized the reduced interest in the environment. In the standard open field and 
social interaction tests, which also include an anxiety component, the beneficial effects of dobutamine were not observed. In contrast, 
captopril normalized all behavioral changes that indicated increased anxiety. In conclusion, the expected similar hemodynamic 
improvement with dobutamine and captopril treatment resulted in improvement of different aspects of the changed behavior of rats with 
myocardial infarction, indicating that there is no direct relationship between hemodynamics and quality of life. The behavioral tests used, 
in combination with our previously described functional hemodynamic measurements, could provide a new basis for evaluating the effects 
of therapy on hemodynamic function as well as the quality of life. 
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1. Introduction 
Treatment of chronic myocardial infarction is directed 
at improving the hemodynamic state of the patient (Guyatt, 
1986) and at interacting with the hypertrophy and remod- 
elling, to delay progression of heart failure (Lamas and 
Pfeffer, 1990). While the former leads to relief of symp- 
toms of congestion, the latter is aimed at improving prog- 
nosis (Pfeffer et al., 1992). 
However, after extensive revalidation programs and 
pharmacological treatment, patients suffering from a healed 
myocardial infarction still have more functional difficulties 
in their normal daily life than their hemodynamic state 
would suggest (Oldridge et al., 1991). This reduced ‘qual- 
ity of life’, including anxiety/depression, loss of interest 
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in environment and in social interactions, sexual difficul- 
ties and sleep disturbances (Olsson et al., 1986; Bulpitt and 
Fletcher, 1988; Bamett, 1991; Oldridge et al., 1991; Rector 
and Cohn, 19921, has become a serious target for therapy 
now. Moreover, the growing population of older people 
who are at risk for heart failure after surviving myocardial 
infarction, due to improved medical care, requires that 
therapy should be directed not only at increasing life 
expectancy, but also the quality of life. 
Rats with experimental myocardial infarction have 
proven to provide a clinically relevant model for hemody- 
namic (Pfeffer et al., 1985; Schoemaker et al., 1990, 
1991a), humoral (Inoue et al., 1987; Hodsman et al., 
19881, structural (Van Krimpen et al., 1991; Smits et al., 
1991, 1992) and survival studies (Pfeffer et al., 1987; 
Sweet et al., 1988). In addition, we have recently reported 
that these rats exhibit behavioral changes that mimic as- 
pects of the decreased quality of life of patients with 
myocardial infarction, including increased anxiety/depres- 
sion, and loss of interest in the environment and social 
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interactions (Schoemaker and Smits, 1994). 
The aim of the present study was to investigate whether 
pharmacological treatment (dobutamine or captopril) that 
improves hemodynamic function in rats with chronic my- 
ocardial infarction also has beneficial effects on their 
behavioral pattern, which could be considered to reflect a 
reduced ‘quality of life’. In our previous studies, we have 
shown that 2 weeks’ intermittent treatment with dobu- 
tamine, a sympathomimetic (Schoemaker et al., 1991b), or 
captopril, an angiotensin I converting enzyme inhibitor, 
(Schoemaker et al., 1991a) improved hemodynamics and 
cardiac function. Moreover, captopril also improved prog- 
nosis in this model (Pfeffer et al., 1987). 
2. Material and methods 
2.1. Animals 
Male Wistar rats (+ 270 g, Winkelman, Borchen, Ger- 
many or T.N.O. Zeist, Netherlands) were used in this 
study. Before surgery the rats were housed in groups of 
3-4, whereas after surgery the rats were housed 2-3 with 
infarct and sham rats randomly divided. The rats had free 
access to standard laboratory chow and tap water in a 
reversed 12 h light/dark cycle (lights off from 9 a.m. to 9 
p.m.>. 
2.2. Myocardial infarction 
Rats were subjected to either coronary artery ligation or 
sham operation, using a modification (Schoemaker et al., 
1990, 1991a) of the method of Fishbein et al. (1978). 
Briefly, animals were anesthetized with pentobarbital (60 
mg/kg i.p.1 and the trachea was intubated (PE-240). The 
skin overlying the fourth intercostal space was cut, and 
underlying muscles were separated and kept aside. The 
thorax was opened after positive pressure respiration was 
started and the heart was carefully pushed to the left by 
applying pressure to the right side of the thorax. A silk 
(6-O) suture was looped under the left descending coronary 
artery near the origin of the pulmonary artery. In sham 
animals the suture was looped through the myocardium, 
right next to the coronary artery. When the heart was 
returned to its normal position, the suture was closed and 
the ribs were pulled together with 3-O silk. The muscles 
were returned to their normal position and the skin was 
closed. 
2.3. Treatment 
Treatment was started 3 weeks after myocardial infarc- 
tion, that is after the healing period (Fishbein et al., 19781, 
and was continued for the rest of the experimental period 
(7-8 weeks after surgery). Dobutamine was given as i.p. 
injections of 1 mg/kg (injected volume 1 ml/kg) twice 
daily. Since dobutamine i.p. caused hemodynamic activa- 
tion, an effect which completely disappeared within 45 
min, the two injections were given 90-180 min apart, 
resulting in at the most stimulation for 90 min per 24 h. 
For further validation of this treatment, see Schoemaker et 
al. (1991b). Control rats were injected twice daily with 
saline (1 ml/kg) to check for effects of this type of daily 
handling. Similar to the hemodynamic study (Schoemaker 
et al., 1991b), behavioral tests were performed at least 18 h 
after the last injection, a time point at which no dobu- 
tamine is present in the circulation, but hemodynamic 
improvement was present. 
Captopril was administered in the drinking water (2 
g/l) (Pfeffer et al., 1985, 19871, and not by using osmotic 
minipumps, as described in our previous studies (Schoe- 
maker et al., 1991a; Van Krimpen et al., 19911, since this 
would have required three extra operations to implant and 
exchange pumps, shortly before or during behavioral tests. 
Moreover, the results from hemodynamic studies with 
anesthetized rats, using captopril in the drinking water 
(Pfeffer et al., 1985, 1987), were comparable to ours in 
conscious rats with captopril administered with osmotic 
minipumps (500 pg/kg . h; Schoemaker et al., 1991a). In 
addition, the 2 g/l captopril in the drinking water im- 
proved survival (Pfeffer et al., 1987). Therefore, it seems 
feasible to expect that the hemodynamics of the treated 
rats were improved at the time of behavioral testing. 
Since rats were socially housed, individual water (con- 
taining captopril) intake was not determined. However, on 
average rats drank 25-30 ml per day, resulting in 50-60 
mg captopril per rat per day. The bioavailability of oral 
dietary captopril in rats is 29% (Singhvi et al., 1981) and 
does not change during chronic treatment. The average 
effective dose of captopril would be then 15 mg per day 
per rat. 
2.4. Behavioral tests 
Starting after 2 weeks’ treatment, behavioral tests were 
performed during the dark period of the light/dark cycle, 
using an open field cage (100 X 100 X 30 cm, floor sur- 
face divided into 36 squares, and illuminated with 40 W 
red light). Equivalent to the functional difficulties in their 
normal daily life of patients, this set-up and tests were 
chosen to match closely the ‘normal daily life’ of labora- 
tory rats; being moved to other cages and mixing with 
other rats. Since pilot studies indicated no significant 
difference in exploratory behavior in the open field follow- 
ing the very first exposure, all rats were allowed to explore 
the open field during a 5 min period, 24 h prior to the first 
test. The following tests were performed twice, with at 
least 24 h in between: 
2.4.1. Free exploration 
This test is a modified version of the free exploration 
test as described by Knardahl and Sagvolden (1979), and is 
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more directed to pure exploration than the standard open 
field test is, because the latter also includes an anxiety 
component. The rat has a choice whether or not to explore 
a new area from its own familiar home cage. To create a 
situation that is as little aversive as possible, the rat was 
allowed 5 min exploration of the open field just prior to 
the test. The rat was placed in the middle of the open field 
cage and left to explore this new area for 5 min. Then, it 
was returned to its home cage (from which the other rat(s) 
had been removed) and placed, with this home cage left 
open, into the open field again. The percentage of time 
spent resting and grooming in the home cage, exploration 
(digging, sniffing, and locomotion combined with sniffing) 
inside the home cage, and exploration of the area outside 
(the edges of the cage and the space above the cage) as 
well as the total time before the rat climbed out of its cage 
into the open field (with a maximum of 10 min) was 
measured (latency), and the test was terminated. The ratio 
of exploration outside/resting, grooming and exploration 
inside was calculated as activity outside/inside. 
For infarcted rats, climbing out of their cage may be 
hampered by physical limitations. To check whether the 
infarcted and sham rats were physically capable of climb- 
ing out of their cages, we placed their cage-mate(s) in a 
closed separate cage right next to the home cage with the 
experimental rat and determined whether the experimental 
rat climbed out of its cage. For the captopril treated rats 
and their respective sham and infarct controls, the time 
before leaving the home cage was measured. 
2.4.2. Forced exploration 
This test is basically a standard open field test, analyzed 
in three different ways. Since it was not possible to 
perform the different analyses at the same time, in three 
separate sessions (twice each) of 5 min, after the rat was 
placed in the middle of the open field, we measured (a> 
percentage of time spent in the comer areas, along the 
walls, or in the middle part, (b) locomotor activity, by 
counting the number of line crossings per 5 min, and (c> 
percentage of time spent on a variety of behavioral ele- 
ments, namely, resting, sniffing * , sniffing with walking * , 
walking only * , exploration of the walls * , rearing * , scan- 
ning, and grooming. The total time spent on exploration 
was determined as the total for the behaviors marked 
with * . 
Table 1 
Characterization of experimental groups 
2.4.3. Social interest 
The rat was placed in the middle of the open field and 
allowed to explore it for 5 min. Then a young adult male 
rat (at least 150 g less in body weight) was introduced as 
far as possible from the experimental rat (BluthC et al., 
1992). The percentage time spent on different elements of 
social behavior including fixation, moving towards, social 
investigation, and aggression/defence (Lehman and 
Adams, 1977; Koolhaas et al., 1983), as well as non-social 
elements including resting, moving away, grooming and 
exploration of the open field itself, was registered during a 
5-min period. Total social behavior was determined as 
time spent on fixation, moving towards, and social investi- 
gation. 
The two free exploration tests and social interaction 
tests were never performed on two consecutive days. 
Moreover, the 5-min habituation prior to these tests was 
used to score one of the three parameters for the forced 
exploration test, since the setting was exactly the same. 
After completion of the experiments, rats were anes- 
thetized with pentobarbital and the hearts were excised. 
Hearts were washed in saline, vessels and atria were 
removed and the ventricles were weighed. The presence of 
extensive left ventricular infarctions was verified visually. 
2.5. Data analysis 
All tests were performed twice, and the average result 
of the two tests was calculated for each rat. Since infarcts 
of less than 20% of the left ventricle have no hemody- 
namic consequences (Schoemaker et al., 199 1 a>, data from 
rats with visually determined small infarcts were excluded 
from further analysis. Since the behavior during the tests 
of rats receiving daily injections of saline, as control for 
dobutamine treatment, and the not specifically handled 
rats, as control for captopril treatment, was not different, 
data obtained from these control groups were pooled. Data 
for groups of rats are presented as means f S.E.M. Differ- 
ences between groups in percentage time spent on certain 
behavioral elements were analyzed using the non-paramet- 
ric Kruskal-Wallis test, followed by post-hoc Tukey test 
(percentages time spent on different behavior within one 
test are not independent). Differences in body weight and 
heart weight, as well as the number of crossings in the 
open field and number of visits into the middle area, were 
n 
Sham 
9 
Infarct 
12 
Infarct + dobutamine 
10 
Infarct + captopril 
8 
Start weight(g) 269 k 3 2715 4 270 f 3 270 * 3 
Body weight(g) 385 rt 9 399 k 10 387 f 13 349* 11 b 
Heart weight (mg) 1148k32 1557 f 64 a 1505 k 63 1070 f 57 b 
Heart/body weight 3.0 * 0.1 4.0 f 0.2 a 3.9 f 0.2 3.1 f 0.2 b 
a Significant difference between rats with infarction and sham rats. b Significant difference between non-treated and treated rats with infarction. 
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tested using one-way analysis of variances, with post-hoc 
test according to Dunnett. Relationships between results of 
different tests were analyzed using linear regression analy- 
sis. Differences are regarded as statistically significant if 
P < 0.05. 
3. Results 
3.1. General 
Coronary artery ligation resulted in transmural infarc- 
tions, except for small ones, in the free wall of the left 
ventricle. The overall mortality was 20% within the first 
24 h. Four rats were excluded from analysis because of too 
small infarctions; two from the non-treated group with 
infarction, and one each from the captopril- and dobu- 
tamine-treated groups. The general characteristics of the 
experimental groups are presented in Table 1. Whereas 
body weights were comparable at the start of the protocol, 
7-8 weeks later captopril treated rats had significantly 
lower body weights than the other groups. Heart weight 
was significantly increased after myocardial infarction and 
was normalized by captopril, but not by dobutamine treat- 
ment. Although both body weight and heart weight were 
reduced by captopril, the heart weight/body weight ratio 
was normalized to sham values in captopril-treated rats 
with myocardial infarction. 
Despite the fact that the behavioral tests were per- 
formed over an extended period of time (1.5-2 weeks), 
with repeated daily exposure to the same setting, no signs 
of habituation or reduced motivation were observed (time 
spent on exploration being 81 f 4 and 79 f 3%; time spent 
in the middle area of the open field 15 f 2 and 17 k 2% in 
the first and second tests, respectively, for all rats together. 
No differences between groups were observed. 
3.2. Free exploration (Fig. 1) 
Sham rats spent little time resting and grooming but 
immediately started exploration in- and outside their cage. 
On average, these rats left their own cage in about 100 s, 
to explore the new environment. Rats with myocardial 
infarction spent significantly more time resting and groom- 
ing in their own cage. This occurred at the expense of 
exploration of the area outside their home cage, since 
exploration inside their home cage was similar to that of 
sham rats. Rats with myocardial infarction took about 160 
s before they left their home cage (Fig. 1). The ratio 
activity outside/inside the home cage before climbing out 
was significantly less in the rats with infarction (2.3 f 0.3 
compared to 3.6 f 0.5). Dobutamine treatment signifi- 
cantly increased the time spent exploring the area outside 
the home cages, without the rats leaving the cage earlier 
than the non-treated infarcted rats did. The increased ex- 
ploration outside the home cage occurred at the expense of 
25 
m sham 
infarct 
infarct+dob. 
400 
300 
z 
% 
200 
$ 
Q 
Tii 
J 
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0 
exploration exploration 
home cage outside 
climb out 
Fig. 1. Time spent on different elements of behavior by sham, non-treated, 
and dobutamine- (dab.) and captopril- (cap.) treated rats with myocardial 
infarction, and latency to leave the home cage in the ‘free exploration 
test’. a Significant difference between rats with infarction and sham rats. 
b Significant difference between non-treated and treated rats with myocar- 
dial infarction. 
both resting and grooming (not significant) and exploration 
inside the home cage, increasing the outside/inside ratio 
significantly (to 4.1 f 0.7). In contrast, captopril had no 
effect on the percentage time spent on the different behav- 
ioral elements (activity outside/inside 2.4 f 0.5). Total 
time before leaving the home cage was more than 50% 
longer than for non-treated rats with infarction. Because of 
the high variability of the latency times, no statistically 
significant differences were found. 
In the situation with the cage-mate of the experimental 
rat in an adjacent cage, all experimental rats immediately 
started to climb out of their cage. In the captopril-treated 
and control groups, we measured this latency. All rats left 
their home cage within 1 min, with no statistical differ- 
ences between groups (mean values: sham 49 + 16 s; 
infarct 27 + 8 s; infarct + captopril 38 IfI 6 s). 
3.3. Forced exploration (Figs. 2 and 3) 
3.3.1. Spatial distribution and locomotor activity 
Sham rats spent about 85% of the time in the comers 
and along the walls, equally divided between the two 
areas. The middle part was only incidentally visited. In- 
farcted rats significantly preferred the corners of the open 
field, at the expense of both the middle (40% less) and the 
wall areas (20% less). Although the difference between 
rats with infarction and sham rats in percentage time spent 
at the middle part did not reach statistical significance, the 
number of visits into the middle part was significantly 
lower for infarcted rats (8.7 * 0.8 compared to 12.4 f 1.8). 
The number of line crossings, as a measure for locomo- 
tion, was almost 200/5 min for sham rats, and was 
significantly reduced to just above 100 in infarcted rats 
(Fig. 2). 
Dobutamine treatment had no effect on any of the 
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75 
0 
m sham 
m infarct 
infarct+dob. 
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Fig. 2. Time spent in different areas of the open field by sham, non-treated, 
and dobutamine- (dab.) and captopril- (cap.) treated rats with myocardiai 
infarction, and number of iine-crossings during 5 min in the ‘forced 
exploration test’. a Significant difference between rats with infarction and 
sham rats. b Significant difference between non-treated and treated rats 
with myocardial infarction. 
above mentioned parameters, whereas captopril signifi- 
cantly affected all infarction induced changes towards 
sham values (except for time spent along the wall) (Fig. 2). 
3.3.2. Exploratory behavior 
Rats with infarction spent significantly less total time 
on exploration compared to sham rats (75 + 2 compared to 
88 f 2% of time). A detailed presentation of the different 
behavioral elements showed that rats with infarction spent 
significantly more time resting and scanning, anxious ex- 
ploration, at the expense of walking and rearing. Sniffing 
and exploration of the wall did not change. Dobutamine 
had no significant effects on either total exploration time 
(74 * 5%) or its distribution over the different behavioral 
elements (Fig. 3). Captopril treatment also did not change 
total time spent on exploration (76 k 4%), but the compo- 
40 
1 
m sham  infarct 
infarct+dob. 
30 m infarct+cap. 
walk + 
rear walk sniff scann 
sniff wall 
Fig. 3. Time spent on different elements of exploratory behavior by sham, 
non-treated, and dobutamine- (dob.) and captopril- (cap.) treated rats with 
myccardial infarction in the ‘forced exploration test’. a Significant differ- 
ence between rats with infarction and sham rats. b Significant difference 
between non-treated and treated rats with myocardial infarction. 
50 1 \ m sham m infarct 
infarct+dob. 
@# infarctccap. 
; 30 
._ c 
s 20 
10 
n 
” 
social mwe 
investigation towards 
fixate rest 
mwe non- 
away social 
Fig. 4. Time spent on different elements of social behavior towards a 
young unfamiliar male rat by sham, non-treated, and dobutamine- (dob.) 
and captopril- (cap.) treated rats with myocardial infarction. a Significant 
difference between rats with infarction and sham rats. b Significant 
difference between non-treated and treated rats with myocardial infarc- 
tion. 
sition underwent significant changes: sniffing and scanning 
significantly decreased, whereas walking and rearing (al- 
though not statistically significant) increased. Resting was 
not affected. 
3.4. Social interest (Fig. 4) 
Sham rats spent 63 f 3% of the time on social behavior 
towards the young male, whereas for rats with infarction 
this was significantly reduced to 44 k 3%. A detailed 
presentation of the elements of social behavior is shown in 
Fig. 4. The active elements of social behavior, such as 
moving towards and social investigation, were reduced in 
rats with infarction, whereas more resting and non-social 
behavior was displayed. Moreover, rats with infarction 
showed more active avoidance of social interactions by 
moving away. 
Dobutamine treatment had no effects on total social 
behavior (45 + 4%) nor on any of its elements (Fig. 4). 
Captopril treatment also had no significant effect on total 
social behavior (49 + 3%). However, the time spent on 
social investigation was significantly increased by capto- 
pril compared to that of non-treated rats with infarction 
(Fig. 4). This occurred at the expense of resting behavior. 
3.5. Correlations between test results 
Major parameters from the different tests, including 
activity outside/inside from the free exploration test; total 
exploration, comer preference, and number of crossings 
from the forced exploration test; and the total social behav- 
ior of the social interaction test, were analyzed for non- 
treated rats, and for all rats (Table 2). It revealed that most 
parameters from different tests were interrelated, with the 
exception of the activity outside/inside of the free explo- 
ration test. For non-treated rats the results from the free 
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Table 2 
Correlation coefficients of statistically significant correlations between 
parameters of different tests 
expl. out/in cross comer social hw/bw 
expl. 0.40 0.41 - 0.47 0.52 - 0.42 
out/in 0.53 ns ns 
cross 0.61 0.55 -“L52 0.32 “k, 
comer ns - 0.49 - 0.62 - 0.43 0.54 
social 0.65 ns Its - 0.33 
hw/bw - 0.67 ns 6.69 0.68 - 0.58 
Italics: values for nontreated rats. Normal: values for all rats. expl.: total 
exploration; out/in: activity outside/inside home cage; cross: number of 
crossings; comer: comer preference; social: total social behavior; hw/bw: 
heart weight/body weight ratio; ns: not statistically significant. 
exploration and forced exploration tests were related: rats 
with high outside/inside ratios showed more exploration, 
more crossings, and lower comer preference in the forced 
exploration test, but no relation was found with the results 
of the social interaction test. For all rats together, the result 
of the free exploration test was only correlated with total 
exploration in the forced exploration test. 
All parameters, except outside/inside ratio, were corre- 
lated with heart weight/body weight ratio. 
4. Discussion 
4.1. Quality of life in myocardial infarcted patients; effects 
of captopril and dobutamine 
In addition to the hemodynamic changes following 
myocardial infarction, patients experience major psycho- 
logical alterations, resulting in a generally reduced sense of 
well being. This reduced quality of life is more pro- 
nounced than the hemodynamic alterations would suggest 
(Oldridge et al., 1991), and includes anxiety/depression, 
loss of interest in environment and social interactions, 
sexual difficulties, and sleep disturbances (Olsson et al., 
1986; Bulpitt and Fletcher, 1988; Bamett, 1991; Oldridge 
et al., 1991; Rector and Cohn, 1992). 
Captopril improves the hemodynamics (Lamas and 
Pfeffer, 1990) and life expectancy (Pfeffer et al., 1992) of 
patients with heart failure. The suggestion that captopril 
also may influence mental function was already raised in 
1986, where it was reported to induce ‘a sense of well 
being’ (Croog et al., 1986). Now there is growing evidence 
that captopril improves the quality of life of patients with 
hypertension (Breckemidge, 1991; Testa et al., 1993) or 
heart failure (Just et al., 1993). This could not be attributed 
directly to peripheral angiotensin converting enzyme (ACE) 
inhibition, and consequent hemodynamic changes, since, 
despite the similar effects of enalapril on hemodynamics 
and prognosis (Consensus Trial Study Group, 1987), the 
effects of enalapril on quality of life are less conclusive 
(Blumenthal et al., 1990; Rector et al., 1993; Testa et al., 
1993). The different effects may be associated with differ- 
ent penetration or binding in the central nerveus system 
(Cushman et al., 1989). 
Chronic intermittent dobutamine treatment for heart 
failure was of high interest during the eighties, because of 
the sustained improvement attained (Leier et al., 1982; 
Liang et al., 1984; Roffman et al., 198% To our knowl- 
edge, no data are available about effects on long-term 
prognosis or quality of life. Increased anxiety may occur, 
but is associated with acute administration (Mertes et al., 
1993). Nevertheless, it is not known whether effects on 
quality of life are related to hemodynamic improvement. In 
the present study, we addressed this question in an animal 
model for heart failure. 
4.2. Quality of life in the model of myocardial infarcted 
rats 
Rats with coronary artery ligation provide a clinically 
relevant model for the consequences of myocardial infarc- 
tion on hemodynamics (Schoemaker et al., 1991a; Pfeffer 
et al., 1985) and survival (Pfeffer et al., 1987; Sweet et al., 
1988). Decreased cardiac output and left ventricular func- 
tion, as well as mortality, are related to infarct size. 
Moreover, we have recently reported behavioral changes in 
this model, changes that mimic aspects of the reduced 
quality of life of patients (Schoemaker and Smits, 1994). 
Behavioral tests showed reduced interest in environment, 
enhanced anxiety/depression, and lower social interest in 
rats with myocardial infarction. The mechanisms underly- 
ing the behavioral changes in rats with infarction are not 
known, but may include changes in neurotransmitter levels 
(Olson and Morgan, 1982) as well as interleukin-1 associ- 
ated ‘sickness behavior’ (Dantzer et al., 1991; Bluthe’ et 
al., 1992). In rats with chronic myocardial infarction, 
increased metabolism in the paraventricular hypothalamus 
and locus coeruleus has been shown (Pate1 et al., 1993). 
4.3. Effects of therapy 
In one of our previous studies on the hemodynamics of 
rats with infarction, we have shown that captopril treat- 
ment, started after the healing period (3-5 weeks after 
infarction), could restore hemodynamics and cardiac func- 
tion (Schoemaker et al., 1991a). Moreover, captopril ther- 
apy also increased long-term survival in these rats (Pfeffer 
et al., 1987). Intermittent dobutamine treatment during the 
same period after infarction (3-5 weeks) resulted in sus- 
tained hemodynamic improvement, comparable to that af- 
ter captopril treatment (Schoemaker et al., 1991b). Effects 
on survival are not known. In the present study we investi- 
gated the effects of these two types of treatment on the 
behavioral changes after myocardial infarction. Behavioral 
tests were started after 2 weeks of treatment, the time point 
at which the above studies reported hemodynamic im- 
provement. Therefore, in this study the hemodynamics of 
the treated rats are expected to be improved. 
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Reduced interest in the environment was studied in the 
free exploration test. Non-treated rats with infarction 
showed reduced interest in the new environment, as indi- 
cated by decreased exploration of the area outside the 
home cage. Treatment with the angiotensin converting 
enzyme inhibitor captopril did not affect this behavior and 
even further prolonged the time before the rat would climb 
out of its cage. In contrast, dobutamine treatment restored 
the interest in the environment, as indicated by the in- 
creased exploration of the area outside the home cage at 
the expense of all activity inside the home cage. The major 
effect of intermittent dobutamine in patients (Leier et al., 
1982) as well as in rats (Buttrick et al., 1991) is a 
peripheral conditioning effect. Although an improved 
physical condition may have contributed to the slightly 
shorter latency in dobutamine-treated rats, all rats were 
capable of climbing out their cage (with the cage-mate in 
an adjacent cage) within 1 min, and thus the much longer 
latency in the free exploration test represents a different 
motivation to climb out rather than a different motor 
response. 
In the forced exploration test, when an anxiety compo- 
nent was present (Knardahl and Sagvolden, 1979), the 
lower interest in the environment, as evidenced by less 
exploratory behavior, was not altered by either treatment. 
However, captopril treatment normalized all aspects of 
increased anxiety - the greater preference for the relatively 
safe area of the open field, the comers; the lower number 
of visits into the least protected area, the middle (Dishman 
et al., 1988; Alonso et al., 1991; Unis et al., 1991); the less 
rearing and more scanning behavior, and the reduced 
locomotor activity, as shown by the shorter distance walked 
(line crossings) as well as by less time spent on walking 
(Alonso et al., 1991; Unis et al., 1991). In contrast, 
dobutamine had no effect on the increased anxiety. 
Reduced social interest in non-treated infarcted rats was 
indicated by lower total social behavior, and more specifi- 
cally by reduced approaching and social investigation, and 
more active avoidance of the other rat. This was not 
changed after dobutamine treatment, whereas captopril 
treatment increased social investigation, though at the ex- 
pense of resting but not of non-social activities. The social 
interaction test in the rat has also been validated as a 
model of anxiety (File, 1981), and again only captopril 
treatment was able to alter social behavior. Anxiolytic 
effects of captopril in rats have been well studied in 
different situations (Barnes et al., 1989; Costa11 et al., 
1990), including the social interaction test. Also clinical 
evidence for anxiolytic effects of captopril is growing 
(Oparil, 1993). R d e uced anxiety has been found as an 
acute effect of captopril. The daily sessions began approxi- 
mately 2 h after the beginning of the dark (= active) 
period. Probably even shortly before the beginning of the 
session the rats will have had captopril, because rats 
normally drink in the beginning of the dark period. We 
therefore cannot exclude that the behavioral changes that 
we observed could be atrributed to ‘acute’ effects of 
circulating captopril. Since chronic but not acute captopril 
improves hemodynamics in this rat model (Schoemaker et 
al., 1991a), the anxiolytic effect in the present study may 
thus represent a direct effect of captopril rather than the 
result of hemodynamic improvement. Dobutamine may 
even increase anxiety, though this is associated with acute 
administration (Mertes et al., 1993) and, hence, is not 
appropriate in the present study. 
Interest in the environment, anxiety and social interest 
may be separate aspects of the changed behavior of rats 
with infarction since they can be affected separately. The 
lack of correlation between the results of the free explo- 
ration test and the results of other tests further supports 
this hypothesis. 
In conclusion, in the present study we compared the 
effects of dobutamine and captopril, shown in previous 
studies to similarly improve hemodynamics, with regard to 
their effects on behavioral changes associated with a re- 
duced quality of life of rats with heart failure. Although 
dobutamine seemed to restore the loss of interest in the 
environment, a sustained increase in anxiety may hamper 
rats to act accordingly in situations in which anxiety plays 
a role. In contrast, captopril treatment restored all behav- 
ioral changes associated with increased anxiety, a response 
which may be attributable to a direct effect of captopril. 
Thus, although the hemodynamic improvement obtained 
with dobutamine and captopril was expected to be similar, 
different aspects of the reduced quality of life were im- 
proved, indicating that there is no direct relationship be- 
tween the two parameters. Since not only improved hemo- 
dynamics and/or prognosis may improve quality of life, 
but also improved quality of life may improve prognosis 
(psychological factors are associated with prognosis in 
each phase of myocardial infarction, Kenyon et al., 1991), 
the relationship between hemodynamics and prognosis, 
and quality of life requires further investigation. The pre- 
sented behavioral tests, in combination with our previously 
described functional hemodynamic measurements, could 
provide a new basis to study treatment that improves the 
hemodynamic state as well as the quality of life. 
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